Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Local proliferation dominates lesional macrophage accumulation in atherosclerosis.

Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby P, Nahrendorf M, Weissleder R, Swirski FK.

Nat Med. 2013 Sep;19(9):1166-72. doi: 10.1038/nm.3258. Epub 2013 Aug 11.

2.

Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis.

Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Gräler M, Heusch G, Levkau B.

Circ Res. 2011 Feb 4;108(3):314-23. doi: 10.1161/CIRCRESAHA.110.235028. Epub 2010 Dec 16.

3.

Proliferating macrophages prevail in atherosclerosis.

Randolph GJ.

Nat Med. 2013 Sep;19(9):1094-5. doi: 10.1038/nm.3316.

PMID:
24013746
4.

Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.

Wang Y, Wang GZ, Rabinovitch PS, Tabas I.

Circ Res. 2014 Jan 31;114(3):421-33. doi: 10.1161/CIRCRESAHA.114.302153. Epub 2013 Dec 2.

5.

CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice.

Manthey HD, Cochain C, Barnsteiner S, Karshovska E, Pelisek J, Koch M, Chaudhari SM, Busch M, Eckstein HH, Weber C, Koenen RR, Zernecke A.

Thromb Haemost. 2013 Dec;110(6):1267-77. doi: 10.1160/TH13-01-0017. Epub 2013 Oct 10.

PMID:
24114205
6.

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.

Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ.

J Clin Invest. 2007 Jan;117(1):195-205.

7.

Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.

Lindau A, Härdtner C, Hergeth SP, Blanz KD, Dufner B, Hoppe N, Anto-Michel N, Kornemann J, Zou J, Gerhardt LM, Heidt T, Willecke F, Geis S, Stachon P, Wolf D, Libby P, Swirski FK, Robbins CS, McPheat W, Hawley S, Braddock M, Gilsbach R, Hein L, von zur Mühlen C, Bode C, Zirlik A, Hilgendorf I.

Basic Res Cardiol. 2016 Mar;111(2):20. doi: 10.1007/s00395-016-0535-8. Epub 2016 Feb 18.

8.

Monocyte and macrophage dynamics during atherogenesis.

Ley K, Miller YI, Hedrick CC.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1506-16. doi: 10.1161/ATVBAHA.110.221127. Review.

9.

The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.

Fenyo IM, Gafencu AV.

Immunobiology. 2013 Nov;218(11):1376-84. doi: 10.1016/j.imbio.2013.06.005. Epub 2013 Jun 19.

PMID:
23886694
10.

Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.

Wang F, Okamoto Y, Inoki I, Yoshioka K, Du W, Qi X, Takuwa N, Gonda K, Yamamoto Y, Ohkawa R, Nishiuchi T, Sugimoto N, Yatomi Y, Mitsumori K, Asano M, Kinoshita M, Takuwa Y.

J Clin Invest. 2010 Nov;120(11):3979-95. doi: 10.1172/JCI42315. Epub 2010 Oct 18. Erratum in: J Clin Invest. 2012 Jan;122(1):419. Retraction in: J Clin Invest. 2012 Mar;122(3):1131.

11.

Macrophage proliferation and apoptosis in atherosclerosis.

Andrés V, Pello OM, Silvestre-Roig C.

Curr Opin Lipidol. 2012 Oct;23(5):429-38. doi: 10.1097/MOL.0b013e328357a379. Review.

PMID:
22964992
12.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

13.

IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, Stellos K, Little KM, Lasitschka F, Doesch A, Hakimi M, Dengler TJ, Giese T, Blessing E, Katus HA, Gleissner CA.

J Immunol. 2014 Nov 1;193(9):4344-55. doi: 10.4049/jimmunol.1400181. Epub 2014 Sep 26.

14.

Xenogenic macrophage immunization reduces atherosclerosis in apolipoprotein E knockout mice.

Yamashita T, Kawashima S, Hirase T, Shinohara M, Takaya T, Sasaki N, Takeda M, Tawa H, Inoue N, Hirata K, Yokoyama M.

Am J Physiol Cell Physiol. 2007 Sep;293(3):C865-73. Epub 2007 Jun 6.

15.

The dynamics of macrophage infiltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.

Ye D, Zhao Y, Hildebrand RB, Singaraja RR, Hayden MR, Van Berkel TJ, Van Eck M.

Am J Pathol. 2011 Jan;178(1):413-22. doi: 10.1016/j.ajpath.2010.11.007. Epub 2010 Dec 23.

16.

Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.

Wei Y, Zhu M, Corbalán-Campos J, Heyll K, Weber C, Schober A.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):796-803. doi: 10.1161/ATVBAHA.114.304723. Epub 2015 Feb 19.

17.

Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis.

Shaposhnik Z, Wang X, Lusis AJ.

J Lipid Res. 2010 Jul;51(7):1962-70. doi: 10.1194/jlr.M005215. Epub 2010 Feb 28.

18.

Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.

Lammers B, Chandak PG, Aflaki E, Van Puijvelde GH, Radovic B, Hildebrand RB, Meurs I, Out R, Kuiper J, Van Berkel TJ, Kolb D, Haemmerle G, Zechner R, Levak-Frank S, Van Eck M, Kratky D.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):67-73. doi: 10.1161/ATVBAHA.110.215814. Epub 2010 Oct 28.

19.

Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.

Grandoch M, Feldmann K, Göthert JR, Dick LS, Homann S, Klatt C, Bayer JK, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Köhrer K, Lehr S, Homey B, Pfeffer K, Fischer JW.

Circ Res. 2015 Apr 10;116(8):e57-68. doi: 10.1161/CIRCRESAHA.116.305723. Epub 2015 Mar 4.

20.

Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.

Wang Y, Parlevliet ET, Geerling JJ, van der Tuin SJ, Zhang H, Bieghs V, Jawad AH, Shiri-Sverdlov R, Bot I, de Jager SC, Havekes LM, Romijn JA, Willems van Dijk K, Rensen PC.

Br J Pharmacol. 2014 Feb;171(3):723-34. doi: 10.1111/bph.12490.

Supplemental Content

Support Center